InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score78
United States Fiscal year ends December CIK 0001368514
$10.36 +0.29% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $10.36 +850.46% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue10.7Operating income−17.3Net income−19.5Fiscal year 2017Revenue22.8 +113.5%Operating income−39.3Net income−43.8Fiscal year 2018Revenue17.0 −25.4%Operating income−60.3Net income−65.7Fiscal year 2019Revenue29.3 +72.8%Operating income−41.4Net income−48.3Fiscal year 2020Revenue42.2 +43.9%Operating income−64.9Net income−75.7EPS, diluted−0.88Fiscal year 2021Revenue80.9 +91.7%Operating income−58.4Net income−71.6EPS, diluted−0.51Fiscal year 2022Revenue154.1 +90.4%Operating income−39.4Net income−65.9EPS, diluted−0.33Fiscal year 2023Revenue258.2 +67.6%Operating income21.6Net income−28.2EPS, diluted−0.13Fiscal year 2024Revenue426.5 +65.2%Operating income139.0Net income197.7EPS, diluted0.81Fiscal year 2025Revenue510.2 +19.6%Operating income191.4Net income146.9 −25.7%EPS, diluted0.60
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.7 22.8 17.0 29.3 42.2 80.9 154.1 258.2 426.5 510.2
Growth +113.5% −25.4% +72.8% +43.9% +91.7% +90.4% +67.6% +65.2% +19.6%
Operating income −17.3 −39.3 −60.3 −41.4 −64.9 −58.4 −39.4 21.6 139.0 191.4
Net income −19.5 −43.8 −65.7 −48.3 −75.7 −71.6 −65.9 −28.2 197.7 146.9
Growth −25.7%
EPS, diluted n/a n/a n/a n/a −0.88 −0.51 −0.33 −0.13 0.81 0.60

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin40.3%Operating margin−162.6%Net margin−183.1%Free cash flow margin−172.1%Fiscal year 2017Gross margin−28.1%Operating margin−172.7%Net margin−192.3%Free cash flow margin−175.5%Fiscal year 2018Gross margin−148.4%Operating margin−354.9%Net margin−387.1%Free cash flow margin−381.4%Fiscal year 2019Operating margin−141.1%Net margin−164.5%Free cash flow margin−272.6%Fiscal year 2020Gross margin−45.2%Operating margin−153.8%Net margin−179.4%Free cash flow margin−271.7%Fiscal year 2021Gross margin1.4%Operating margin−72.1%Net margin−88.5%Free cash flow margin−155.5%Fiscal year 2022Gross margin22.9%Operating margin−25.5%Net margin−42.8%Free cash flow margin−47.6%Fiscal year 2023Gross margin34.4%Operating margin8.4%Net margin−10.9%Free cash flow margin1.6%Fiscal year 2024Gross margin51.5%Operating margin32.6%Net margin46.4%Free cash flow margin25.9%Fiscal year 2025Gross margin57.4%Operating margin37.5%Net margin28.8%Free cash flow margin5.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 40.3% −28.1% −148.4% n/a −45.2% 1.4% 22.9% 34.4% 51.5% 57.4%
Operating margin −162.6% −172.7% −354.9% −141.1% −153.8% −72.1% −25.5% 8.4% 32.6% 37.5%
Net margin −183.1% −192.3% −387.1% −164.5% −179.4% −88.5% −42.8% −10.9% 46.4% 28.8%
Free cash flow margin −172.1% −175.5% −381.4% −272.6% −271.7% −155.5% −47.6% 1.6% 25.9% 5.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−18.3Capital expenditure−0.1Free cash flow−18.3Fiscal year 2017Operating cash flow−37.3Capital expenditure−2.7Free cash flow−39.9Fiscal year 2018Operating cash flow−62.7Capital expenditure−2.1Free cash flow−64.8Fiscal year 2019Operating cash flow−76.2Capital expenditure−3.8Free cash flow−80.0Fiscal year 2020Operating cash flow−102.0Capital expenditure−12.7Free cash flow−114.7Fiscal year 2021Operating cash flow−112.4Capital expenditure−13.5Free cash flow−125.9Fiscal year 2022Operating cash flow−59.5Capital expenditure−13.9Free cash flow−73.4Fiscal year 2023Operating cash flow8.8Capital expenditure−4.8Free cash flow4.0Buybacks0.0Fiscal year 2024Operating cash flow118.7Capital expenditure−8.2Free cash flow110.4 +2,641.3%Buybacks0.0Fiscal year 2025Operating cash flow50.4Capital expenditure−22.6Free cash flow27.8 −74.8%Buybacks−31.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −18.3 −37.3 −62.7 −76.2 −102.0 −112.4 −59.5 8.8 118.7 50.4
Capital expenditure −0.1 −2.7 −2.1 −3.8 −12.7 −13.5 −13.9 −4.8 −8.2 −22.6
Free cash flow −18.3 −39.9 −64.8 −80.0 −114.7 −125.9 −73.4 4.0 110.4 27.8
Growth +2,641.3% −74.8%
Buybacks n/a n/a n/a n/a n/a n/a n/a 0.0 0.0 −31.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash9.9Total debt1.8Net cash (debt)8.1Shareholders’ equity−4.5Fiscal year 2017Cash43.1Total debt2.8Net cash (debt)40.3Shareholders’ equity40.3Debt to equity0.07Fiscal year 2018Cash26.8Total debt2.8Net cash (debt)24.0Shareholders’ equity19.8Debt to equity0.14Fiscal year 2019Cash26.8Total debt0.0Net cash (debt)26.8Shareholders’ equity26.2Debt to equity0.00Fiscal year 2020Cash55.9Shareholders’ equity88.2Fiscal year 2021Cash51.1Shareholders’ equity141.2Fiscal year 2022Cash86.5Shareholders’ equity152.0Fiscal year 2023Cash51.4Shareholders’ equity135.2Fiscal year 2024Cash103.1Total debt72.3Net cash (debt)30.8Shareholders’ equity349.0Debt to equity0.21Fiscal year 2025Cash87.6Total debt72.1Net cash (debt)15.5Shareholders’ equity477.3Debt to equity0.15
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 9.9 43.1 26.8 26.8 55.9 51.1 86.5 51.4 103.1 87.6
Total debt 1.8 2.8 2.8 0.0 n/a n/a n/a n/a 72.3 72.1
Net cash (debt) 8.1 40.3 24.0 26.8 n/a n/a n/a n/a 30.8 15.5
Shareholders’ equity −4.5 40.3 19.8 26.2 88.2 141.2 152.0 135.2 349.0 477.3
Debt to equity n/a 0.07 0.14 0.00 n/a n/a n/a n/a 0.21 0.15

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
10.7 22.8 17.0 29.3 42.2 80.9 154.1 258.2 426.5 510.2
Growth +113.5% −25.4% +72.8% +43.9% +91.7% +90.4% +67.6% +65.2% +19.6%
1.6 29.2 42.2 39.5 61.3 79.8 118.8 169.3 206.9 217.4
4.3 −6.4 −25.2 n/a −19.1 1.2 35.3 88.9 219.6 292.8
Growth −248.9% +2,906.4% +152.2% +146.8% +33.3%
7.7 5.6 3.9 2.3 5.9 3.6 3.6 3.3 1.8 4.8
8.5 18.8 22.5 25.9 35.1 42.9 52.5 59.0 74.1 91.6
−17.3 −39.3 −60.3 −41.4 −64.9 −58.4 −39.4 21.6 139.0 191.4
Growth +542.5% +37.7%
−19.5 n/a n/a n/a n/a n/a −65.9 −28.2 125.7 182.7
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 −72.0 35.7
−19.5 −43.8 −65.7 −48.3 −75.7 −71.6 −65.9 −28.2 197.7 146.9
Growth −25.7%
Per share
n/a n/a n/a n/a −0.88 −0.51 −0.33 −0.13 0.85 0.62
n/a n/a n/a n/a −0.88 −0.51 −0.33 −0.13 0.81 0.60
Growth −25.9%
n/a n/a n/a n/a 86.1 139.6 197.9 224.0 233.1 238.3
n/a n/a n/a n/a 86.1 139.6 197.9 224.0 243.3 244.9
Growth +62.0% +41.8% +13.2% +8.6% +0.6%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 64.6% a year over five years.
  • Operating margin is up 191.3 points on five years ago, at 37.5%.
  • A net loss in 8 of 10 years on file.